20.500.12556/DiRROS-17940 Cathepsin D and plasminogen activator inhibitor type 1 in normal, benign and alignant ovarian tissues a preliminary report Katepsin D in inhibitorji ter aktivatorji plasminogena tipa 1 v normalnem, benignem in malignem ovarijskem tkivu uvodno poročilo Background. The aim of the present study was to determine the concentration ofcathepsin D (Cath D) and plasminogen activator inhibitor type 1 (PAI-1) in normal ovarian tissues, benign and malignant ovarian tumor tissues, and to asses relationship between Cath D and PAI-1 content, and some clinical and pathohistological parameters. Materials and methods. Cath D contents and PAI-1concentrations were determined (using immunoradiometric ELSA-Cath D assayand commercial IMUDIND R ELISA immunoassay, respectively) in 35 samples: 10 normal ovarii, 10 benign, 10 primary malignant and 5 metastatic ovarian tumors. Results. The concentrations of Cath D were significantly higher in malignant (32.89+-14.26 pmol/mg protein ) and metastatic (31.42+-10.24 pmol/mgprotein), than in normal (13.68+-4.03 pmol/mg protein) and benign (17.89+-13.13 pmol/mg protein) ovarian tissues. There was no statistical differences in the concentrations of PAI-1 between normal, benign, malignant and metastatic tumor specimens. The concentrations of Cath D as well as PAI-1 did not correlate to the age of patients, menopausal status, parity, GOG risk group, clinical stage or pathohistological grading. Conclusion. Concentrationsof Cath D (but not PAI-1) were significantly increased in malignant and metastatic ovarian tumor tissues when compared to normal and benign ovarian tumor samples; they were independent from pathohistological andclinical parameters. Izhodišča. Študijo smo opravili z namenom, da bi določili koncentracijo katepsina D in aktivatorjev ter inhibitorjev plasminogena tipa 1 (PAI-1) v normalnem ovarijskem tkivu ter v tkivu benignega in malignega tumorja ter ocenili razmerje med vsebnostjo katepsina D in PAI-1 in še druge klinične ter patohistološke parametre. Material in metode. V 35 vzorcih (10 vzorcev normalnega ovarijskega tkiva, 10 vzrocev benignega, 10 vzrocev malignega tumorskega tkiva in 5 vzorcev metastatskega ovarijskega tkiva) smo izmerili vsebnost katepsina D (izmerjeno z imunoradiometrično metodo ELISA-Cath D) in koncentracijo PAI-1 (izmerjeno s komercialno imunsko metodo IMUDINDR ELISA). Rezultati. Koncentracija katepsinov D so bile bistveno višje v malignem (32.89+- 14.26 pmol/mg protein) in metastatskem tkivu (31.42 +- 10.24 pmol/mg protein) kot pa v normalnem ovarijskem tkivu (13.68 +- 14.03 pmol/mg protein) ali tkivu benignega ovarijskega tumorja (17.89 +- 13.13 pmol/mg protein). Med koncentracijami PAI-1 v vzorcih normalnega tkiva in vzorcih benignega in malignega tumorskega tkiva ni bilo ugotovljenih statistično pomembnih razlik. Koncentracije katepsina D in PAI-1 tudi niso bile v korelaciji s starostjo bolnic, menopavzo, gravidnistjo, rizičnim GOG skupinam, kliničnemu stadije in patohistološko stopnjo tumorja. Zaključki. Koncentracije katepsina D so bile pomembno večje v malignem in metastatskem ovarijskem tkivu, medtem ko koncentracije PAI-1 niso bile povečane. Koncentracije katepsinov niso bile odvisne od patohistoloških in kliničnih parametrov. true false true Slovenian Medical Association - Slovenian Association of Radiology, Nuclear Medicine Society, Slovenian Society far Radiotherapy and Oncology, and Slovenian Cancer Society Ljubljana Angleški jezik Slovenski jezik by Authors Neznano 2024-01-23 09:53:58 2024-01-23 09:53:58 2024-01-24 03:36:09 0000-00-00 00:00:00 2000 0 0 BSDOCID51340; str. 41-47 št. 1 Letn. 34 March 2000 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 2000-03-01 616-006 1318-2099 11320281 RAZ_Sprem_Marina_2000.pdf RAZ_Sprem_Marina_2000.pdf 1 1C6BCCFA14ADF6A5E13A441CC7CB3C8B 219795eda1768cd6340f2e73ca105090b7cf45bd0b1a215050372b29bf2e033d 1aff681c-b9cd-11ee-b0d4-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=24331 Onkološki inštitut Ljubljana 0 0 0